Skip to content

Mental practice based rehabilitation training aimed at improving arm function and performance of daily activities in stroke: a randomised clinical trial

(Cost)effectiveness of a mental practice based rehabilitation training in patients with an unilateral stroke: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33487341
Enrollment
160
Registered
2008-01-14
Start date
2008-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke/neurorehabilitation Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

Intervention: Mental practice training: training programme three times a day (10 - 15 minutes) during 10 weeks in additional to therapy as usual. The training is guided by CD-rom. Different training

Sponsors

The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. First ever stroke 2. Post-stroke time of 2 - 6 weeks 3. Clinically diagnosed central paresis of the arm/hand with strength Medical Research Council (MRC) grade 1 to 3 of the elbow flexors at entry into the study 4. Age between 18 and 85 years, male and female 5. Fair cognitive level (Mini Mental State Examination [MMSE] score above 23) 6. No severe additional neurological, orthopaedic, rheumatoid or cardiac impairments prior to stroke 7. No severely impaired communication as to comprehension

Exclusion criteria

Exclusion criteria: Does not comply with the above inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Upper extremity functioning assessed on activity level: 1. Wolf Motor Function test 2. Motor Activity Log Both primary and secondary outcome measures will be assessed at baseline, after 10 weeks and 6 and 12 months.

Secondary

MeasureTime frame
Upper extremity functioning assessed on impairment and participation level: 1. Impairment: Brunnstrom-Fugl-Meyer test 2. Participation: 2.1. Impact on Participation and Autonomy questionnaire 2.2. Quality of life: EuroQol (EQ-6D) Both primary and secondary outcome measures will be assessed at baseline, after 10 weeks and 6 and 12 months.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026